Search

Displaying results 9311 - 9320 of 10000 in total
  1. Drug

    Estradiol cypionate

    go.drugbank.com/drugs/DB13954
    ApprovedVet approved

    Estradiol Cypionate is a pro-drug ester of [DB00783], a naturally occurring hormone that circulates endogenously within the human body. … [DB00783] is commonly produced with an ester side-chain as endogenous estradiol has very low oral bioavailability on its own (2-10%).

    Mixtures: FEMELIN®, FEMELIN®Categories: P-glycoprotein substrates, Cytochrome P-450 Substrates
  2. Drug

    Sarracenia Purpurea

    go.drugbank.com/drugs/DB13965
    ApprovedWithdrawn

    It was used as an injectable pain reliever and during the 19th century, _Sarracenia purpurea_ was used as a treatment of smallpox [A32509]. … It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities [A32509, A32510].

    Synonyms: Sarracenia purpurea l.Products: P-Bloc
  3. Drug

    Lonoctocog alfa

    go.drugbank.com/drugs/DB13998
    ApprovedInvestigational

  4. Drug

    p-Phenylenediamine

    go.drugbank.com/drugs/DB14141
    Approved

    Synonyms: 4-Aminoaniline, p-DiaminobenzeneSalts: p-Phenylenediamine dihydrochloride
  5. Drug

    Echinacea

    go.drugbank.com/drugs/DB14240
    ApprovedInvestigational

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers
  6. Drug

    Calcium phosphate dihydrate

    go.drugbank.com/drugs/DB14481
    Approved

    Mixtures: NAVI Black and C-Clinic
  7. Drug

    Zinc acetate

    go.drugbank.com/drugs/DB14487
    ApprovedInvestigational

    Mixtures: Diphenhydramine D, CALPRAX CLEAR®Products: Senior B, Neat 3B Baby B
  8. Drug

    Willow bark

    go.drugbank.com/drugs/DB14691
    Approved

    Mixtures: Miller's Formula No. 1
  9. Drug

    Etrasimod

    go.drugbank.com/drugs/DB14766
    ApprovedInvestigational

    Etrasimod is a synthetic next-generation selective Sphingosine 1-phosphate (S1P) receptor modulator that targets the S1P<sub>1,4,5</sub> with no detectable activity on S1P<sub>2</sub> and S1P<sub>3</sub … [L48501] The European Commission also approved the marketing of etrasimod on February 19, 2024.[L50998]

    Categories: Cytochrome P-450 Substrates, Heterocyclic Compounds, 2-Ring
  10. Drug

    GDC-0425

    go.drugbank.com/drugs/DB14791
    Investigational

    GDC-0425 is under investigation in clinical trial NCT01359696 (A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory

    Categories: Heterocyclic Compounds, 1-Ring